CEO, Bayer HealthCare
Dr. Jörg Reinhardt has been Chairman of the Board of Management of Bayer HealthCare AG and Chairman of the Bayer HealthCare Executive Committee since August 15, 2010.
Dr. Jörg Reinhardt, born on March 11, 1956 in Homburg in the German state of Saarland, studied pharmaceutical sciences at Saarland University in Saarbrücken. After obtaining his doctorate in 1981, he started his career with Sandoz, a predecessor company of Novartis, in 1982, holding various managerial positions of increasing responsibility in research and development. He was appointed Head of Corporate Development in 1994.
After the formation of Novartis in 1996, he served as Head of Preclinical Development and Project Management before being appointed Global Head of Pharma Development in 1999. In November 2005 he was appointed CEO of the Vaccines & Diagnostics Division, Boston, United States. At the end of 2008, Reinhardt returned to Switzerland to become Chief Operating Officer (COO) of Novartis, a position he held until the end of January 2010. In this capacity Reinhardt was responsible for all four of the group’s divisions as well as for Human Resources, IT, Corporate Affairs and Communications. He was also a member of the company’s Executive Committee.
From 2000 until January 2010, Reinhardt also served as Chairman of the Board of Directors of the Genomics Institute of the Novartis Foundation in La Jolla, California. From 2001 through 2004 he was a member of the Supervisory Board of MorphoSys AG, Germany, which specializes in researching and developing monoclonal antibodies.
Jörg Reinhardt is married and has two grown-up children.